<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: 4 Reasons Why Susan Boyle Is &amp; Is Not Like A Penny Stock&#8230;</title>
	<atom:link href="http://www.timothysykes.com/2009/04/4-reasons-why-susan-boyle-is-is-not-like-a-penny-stock.../feed/" rel="self" type="application/rss+xml" />
	<link>http://www.timothysykes.com/</link>
	<description>How To Trade Penny Stocks Without The Stock Promoter BS</description>
	<lastBuildDate>Thu, 09 Feb 2012 06:11:00 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Buddy</title>
		<link>http://www.timothysykes.com/comment-page-1/#comment-39629</link>
		<dc:creator>Buddy</dc:creator>
		<pubDate>Mon, 20 Apr 2009 17:53:54 +0000</pubDate>
		<guid isPermaLink="false">http://test.timothysykes.com/?p=5014#comment-39629</guid>
		<description>Sure... a piece of crap that has a phase III headed by the NCI (with 11 other prominent centers on board) for metastatic melanoma to the liver, (along with a 4 phase II trials) that should be submitting a NDA before years end.

Yes there is much &quot;crap&quot; out there, but it takes more than just looking at a chart to find them. But hey PLEASE short DCTH. Just get out before they announce 75% enrollment and an accelerated time line to NDA submission.

Good luck.</description>
		<content:encoded><![CDATA[<p>Sure&#8230; a piece of crap that has a phase III headed by the NCI (with 11 other prominent centers on board) for metastatic melanoma to the liver, (along with a 4 phase II trials) that should be submitting a NDA before years end.</p>
<p>Yes there is much &#8220;crap&#8221; out there, but it takes more than just looking at a chart to find them. But hey PLEASE short DCTH. Just get out before they announce 75% enrollment and an accelerated time line to NDA submission.</p>
<p>Good luck.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Buddy</title>
		<link>http://www.timothysykes.com/comment-page-1/#comment-83257</link>
		<dc:creator>Buddy</dc:creator>
		<pubDate>Mon, 20 Apr 2009 17:53:54 +0000</pubDate>
		<guid isPermaLink="false">http://test.timothysykes.com/?p=5014#comment-83257</guid>
		<description>Sure... a piece of crap that has a phase III headed by the NCI (with 11 other prominent centers on board) for metastatic melanoma to the liver, (along with a 4 phase II trials) that should be submitting a NDA before years end.

Yes there is much &quot;crap&quot; out there, but it takes more than just looking at a chart to find them. But hey PLEASE short DCTH. Just get out before they announce 75% enrollment and an accelerated time line to NDA submission.

Good luck.</description>
		<content:encoded><![CDATA[<p>Sure&#8230; a piece of crap that has a phase III headed by the NCI (with 11 other prominent centers on board) for metastatic melanoma to the liver, (along with a 4 phase II trials) that should be submitting a NDA before years end.</p>
<p>Yes there is much &#8220;crap&#8221; out there, but it takes more than just looking at a chart to find them. But hey PLEASE short DCTH. Just get out before they announce 75% enrollment and an accelerated time line to NDA submission.</p>
<p>Good luck.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Melody</title>
		<link>http://www.timothysykes.com/comment-page-1/#comment-39628</link>
		<dc:creator>Melody</dc:creator>
		<pubDate>Mon, 20 Apr 2009 04:19:05 +0000</pubDate>
		<guid isPermaLink="false">http://test.timothysykes.com/?p=5014#comment-39628</guid>
		<description>lol..interesting analogy..I wonder if her future album will sell better than william hung&#039;s</description>
		<content:encoded><![CDATA[<p>lol..interesting analogy..I wonder if her future album will sell better than william hung&#8217;s</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Melody</title>
		<link>http://www.timothysykes.com/comment-page-1/#comment-83256</link>
		<dc:creator>Melody</dc:creator>
		<pubDate>Mon, 20 Apr 2009 04:19:05 +0000</pubDate>
		<guid isPermaLink="false">http://test.timothysykes.com/?p=5014#comment-83256</guid>
		<description>lol..interesting analogy..I wonder if her future album will sell better than william hung&#039;s</description>
		<content:encoded><![CDATA[<p>lol..interesting analogy..I wonder if her future album will sell better than william hung&#8217;s</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Timothy Sykes</title>
		<link>http://www.timothysykes.com/comment-page-1/#comment-39627</link>
		<dc:creator>Timothy Sykes</dc:creator>
		<pubDate>Sun, 19 Apr 2009 22:21:20 +0000</pubDate>
		<guid isPermaLink="false">http://test.timothysykes.com/?p=5014#comment-39627</guid>
		<description>DCTH is a piece of crap just like that guy...but i havent shorted it yet as crap rises before going splat</description>
		<content:encoded><![CDATA[<p>DCTH is a piece of crap just like that guy&#8230;but i havent shorted it yet as crap rises before going splat</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Timothy Sykes</title>
		<link>http://www.timothysykes.com/comment-page-1/#comment-83255</link>
		<dc:creator>Timothy Sykes</dc:creator>
		<pubDate>Sun, 19 Apr 2009 22:21:20 +0000</pubDate>
		<guid isPermaLink="false">http://test.timothysykes.com/?p=5014#comment-83255</guid>
		<description>DCTH is a piece of crap just like that guy...but i havent shorted it yet as crap rises before going splat</description>
		<content:encoded><![CDATA[<p>DCTH is a piece of crap just like that guy&#8230;but i havent shorted it yet as crap rises before going splat</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: JIM</title>
		<link>http://www.timothysykes.com/comment-page-1/#comment-39626</link>
		<dc:creator>JIM</dc:creator>
		<pubDate>Sun, 19 Apr 2009 17:48:52 +0000</pubDate>
		<guid isPermaLink="false">http://test.timothysykes.com/?p=5014#comment-39626</guid>
		<description>I want to thank you for SHORTING DELCATH SYSTEMS (DCTH)

Your SHORT CALL on DELCATH SYSTEMS is 100% --&gt; WRONG

And I am going to enjoy your Money !!!

Here is WHY :

The CEO of DCTH, Richard Taney, gave an investor presentation in October (in Boston) that stated that he expects DCTH to generate IMMENSE annual revenues based on the company&#039;s ability to capture 5% to 20% market share of the annual liver cancer market of just the United States:

DCTH&#039;s CEO forecasts the following potential Annual Revenues based on the following market share assumptions:

5% market share ----&gt; $241 million in Annual Revenue
10% market share ----&gt; $482 million in Annual Revenue
15% market share ----&gt; $724 million in Annual Revenue
20% market share ----&gt; $965 million in Annual Revenue

==================================================
DCTH only has ----&gt; 25 Million Shares Outstanding
==================================================

Assuming 80% Profit Margins DCTH could earn:

5% market share ---&gt; $ 72 Million in Net Profits Annually --&gt;
                                    EPS of $7+ a share
10% market share ----&gt; $144 Million in Net Profits Annually --&gt;
                                    EPS of $15+ a share
15% market share ----&gt; $216 Million in Net Profits Annually --&gt;
                                    EPS of $23 + a share
20% market share ----&gt; $290 Million in Net Profits Annually --&gt;
                                    EPS of $30 + a share

DCTH is also entitled to the use of a very valuable Net Operating Loss Carryforward of more than --&gt; $90 Million Dollars.

Any mention of an FDA Approval for DCTH&#039;s technology .... Would be like setting a lit match to Gasoline

Here are 2 HINTS for you - your followers &amp; ur ---&gt; SHORT RECOMMENDATION:

1)   These  X-Rays are published in &quot;The Journal of Clinical Oncology&quot;

These are the XRAYS of a DELCATH PATIENT who EXPERIENCED a ---&gt; COMPLETE REMISSION from LIVER CANCER
LINK:
http://jco.ascopubs.org/content/vol23/issue15/images/large/zlj0150522160003.jpeg

2)    This was DCTH ---&gt; Featured on ABC NIGHTLY NEWS w/ CHARLES GIBSON
LINK: DCTH on ABC NEWS in FEBRUARY 2009
http://abcnews.go.com/Video/playerIndex?id=6807281


Best of Luck to You ----&gt; You are Going to Need IT !!!!</description>
		<content:encoded><![CDATA[<p>I want to thank you for SHORTING DELCATH SYSTEMS (DCTH)</p>
<p>Your SHORT CALL on DELCATH SYSTEMS is 100% &#8211;&gt; WRONG</p>
<p>And I am going to enjoy your Money !!!</p>
<p>Here is WHY :</p>
<p>The CEO of DCTH, Richard Taney, gave an investor presentation in October (in Boston) that stated that he expects DCTH to generate IMMENSE annual revenues based on the company&#8217;s ability to capture 5% to 20% market share of the annual liver cancer market of just the United States:</p>
<p>DCTH&#8217;s CEO forecasts the following potential Annual Revenues based on the following market share assumptions:</p>
<p>5% market share &#8212;-&gt; $241 million in Annual Revenue<br />
10% market share &#8212;-&gt; $482 million in Annual Revenue<br />
15% market share &#8212;-&gt; $724 million in Annual Revenue<br />
20% market share &#8212;-&gt; $965 million in Annual Revenue</p>
<p>==================================================<br />
DCTH only has &#8212;-&gt; 25 Million Shares Outstanding<br />
==================================================</p>
<p>Assuming 80% Profit Margins DCTH could earn:</p>
<p>5% market share &#8212;&gt; $ 72 Million in Net Profits Annually &#8211;&gt;<br />
                                    EPS of $7+ a share<br />
10% market share &#8212;-&gt; $144 Million in Net Profits Annually &#8211;&gt;<br />
                                    EPS of $15+ a share<br />
15% market share &#8212;-&gt; $216 Million in Net Profits Annually &#8211;&gt;<br />
                                    EPS of $23 + a share<br />
20% market share &#8212;-&gt; $290 Million in Net Profits Annually &#8211;&gt;<br />
                                    EPS of $30 + a share</p>
<p>DCTH is also entitled to the use of a very valuable Net Operating Loss Carryforward of more than &#8211;&gt; $90 Million Dollars.</p>
<p>Any mention of an FDA Approval for DCTH&#8217;s technology &#8230;. Would be like setting a lit match to Gasoline</p>
<p>Here are 2 HINTS for you &#8211; your followers &amp; ur &#8212;&gt; SHORT RECOMMENDATION:</p>
<p>1)   These  X-Rays are published in &#8220;The Journal of Clinical Oncology&#8221;</p>
<p>These are the XRAYS of a DELCATH PATIENT who EXPERIENCED a &#8212;&gt; COMPLETE REMISSION from LIVER CANCER<br />
LINK:<br />
<a href="http://jco.ascopubs.org/content/vol23/issue15/images/large/zlj0150522160003.jpeg" rel="nofollow">http://jco.ascopubs.org/content/vol23/issue15/images/large/zlj0150522160003.jpeg</a></p>
<p>2)    This was DCTH &#8212;&gt; Featured on ABC NIGHTLY NEWS w/ CHARLES GIBSON<br />
LINK: DCTH on ABC NEWS in FEBRUARY 2009<br />
<a href="http://abcnews.go.com/Video/playerIndex?id=6807281" rel="nofollow">http://abcnews.go.com/Video/playerIndex?id=6807281</a></p>
<p>Best of Luck to You &#8212;-&gt; You are Going to Need IT !!!!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: JIM</title>
		<link>http://www.timothysykes.com/comment-page-1/#comment-83254</link>
		<dc:creator>JIM</dc:creator>
		<pubDate>Sun, 19 Apr 2009 17:48:52 +0000</pubDate>
		<guid isPermaLink="false">http://test.timothysykes.com/?p=5014#comment-83254</guid>
		<description>I want to thank you for SHORTING DELCATH SYSTEMS (DCTH)

Your SHORT CALL on DELCATH SYSTEMS is 100% --&gt; WRONG

And I am going to enjoy your Money !!!

Here is WHY :

The CEO of DCTH, Richard Taney, gave an investor presentation in October (in Boston) that stated that he expects DCTH to generate IMMENSE annual revenues based on the company&#039;s ability to capture 5% to 20% market share of the annual liver cancer market of just the United States:

DCTH&#039;s CEO forecasts the following potential Annual Revenues based on the following market share assumptions:

5% market share ----&gt; $241 million in Annual Revenue
10% market share ----&gt; $482 million in Annual Revenue
15% market share ----&gt; $724 million in Annual Revenue
20% market share ----&gt; $965 million in Annual Revenue

==================================================
DCTH only has ----&gt; 25 Million Shares Outstanding
==================================================

Assuming 80% Profit Margins DCTH could earn:

5% market share ---&gt; $ 72 Million in Net Profits Annually --&gt;
                                    EPS of $7+ a share
10% market share ----&gt; $144 Million in Net Profits Annually --&gt;
                                    EPS of $15+ a share
15% market share ----&gt; $216 Million in Net Profits Annually --&gt;
                                    EPS of $23 + a share
20% market share ----&gt; $290 Million in Net Profits Annually --&gt;
                                    EPS of $30 + a share

DCTH is also entitled to the use of a very valuable Net Operating Loss Carryforward of more than --&gt; $90 Million Dollars.

Any mention of an FDA Approval for DCTH&#039;s technology .... Would be like setting a lit match to Gasoline

Here are 2 HINTS for you - your followers &amp; ur ---&gt; SHORT RECOMMENDATION:

1)   These  X-Rays are published in &quot;The Journal of Clinical Oncology&quot;

These are the XRAYS of a DELCATH PATIENT who EXPERIENCED a ---&gt; COMPLETE REMISSION from LIVER CANCER
LINK:
http://jco.ascopubs.org/content/vol23/issue15/images/large/zlj0150522160003.jpeg

2)    This was DCTH ---&gt; Featured on ABC NIGHTLY NEWS w/ CHARLES GIBSON
LINK: DCTH on ABC NEWS in FEBRUARY 2009
http://abcnews.go.com/Video/playerIndex?id=6807281


Best of Luck to You ----&gt; You are Going to Need IT !!!!</description>
		<content:encoded><![CDATA[<p>I want to thank you for SHORTING DELCATH SYSTEMS (DCTH)</p>
<p>Your SHORT CALL on DELCATH SYSTEMS is 100% &#8211;&gt; WRONG</p>
<p>And I am going to enjoy your Money !!!</p>
<p>Here is WHY :</p>
<p>The CEO of DCTH, Richard Taney, gave an investor presentation in October (in Boston) that stated that he expects DCTH to generate IMMENSE annual revenues based on the company&#8217;s ability to capture 5% to 20% market share of the annual liver cancer market of just the United States:</p>
<p>DCTH&#8217;s CEO forecasts the following potential Annual Revenues based on the following market share assumptions:</p>
<p>5% market share &#8212;-&gt; $241 million in Annual Revenue<br />
10% market share &#8212;-&gt; $482 million in Annual Revenue<br />
15% market share &#8212;-&gt; $724 million in Annual Revenue<br />
20% market share &#8212;-&gt; $965 million in Annual Revenue</p>
<p>==================================================<br />
DCTH only has &#8212;-&gt; 25 Million Shares Outstanding<br />
==================================================</p>
<p>Assuming 80% Profit Margins DCTH could earn:</p>
<p>5% market share &#8212;&gt; $ 72 Million in Net Profits Annually &#8211;&gt;<br />
                                    EPS of $7+ a share<br />
10% market share &#8212;-&gt; $144 Million in Net Profits Annually &#8211;&gt;<br />
                                    EPS of $15+ a share<br />
15% market share &#8212;-&gt; $216 Million in Net Profits Annually &#8211;&gt;<br />
                                    EPS of $23 + a share<br />
20% market share &#8212;-&gt; $290 Million in Net Profits Annually &#8211;&gt;<br />
                                    EPS of $30 + a share</p>
<p>DCTH is also entitled to the use of a very valuable Net Operating Loss Carryforward of more than &#8211;&gt; $90 Million Dollars.</p>
<p>Any mention of an FDA Approval for DCTH&#8217;s technology &#8230;. Would be like setting a lit match to Gasoline</p>
<p>Here are 2 HINTS for you &#8211; your followers &amp; ur &#8212;&gt; SHORT RECOMMENDATION:</p>
<p>1)   These  X-Rays are published in &#8220;The Journal of Clinical Oncology&#8221;</p>
<p>These are the XRAYS of a DELCATH PATIENT who EXPERIENCED a &#8212;&gt; COMPLETE REMISSION from LIVER CANCER<br />
LINK:<br />
<a href="http://jco.ascopubs.org/content/vol23/issue15/images/large/zlj0150522160003.jpeg" rel="nofollow">http://jco.ascopubs.org/content/vol23/issue15/images/large/zlj0150522160003.jpeg</a></p>
<p>2)    This was DCTH &#8212;&gt; Featured on ABC NIGHTLY NEWS w/ CHARLES GIBSON<br />
LINK: DCTH on ABC NEWS in FEBRUARY 2009<br />
<a href="http://abcnews.go.com/Video/playerIndex?id=6807281" rel="nofollow">http://abcnews.go.com/Video/playerIndex?id=6807281</a></p>
<p>Best of Luck to You &#8212;-&gt; You are Going to Need IT !!!!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: coen</title>
		<link>http://www.timothysykes.com/comment-page-1/#comment-39625</link>
		<dc:creator>coen</dc:creator>
		<pubDate>Sun, 19 Apr 2009 15:20:50 +0000</pubDate>
		<guid isPermaLink="false">http://test.timothysykes.com/?p=5014#comment-39625</guid>
		<description>The ebook &#039;email system&#039; (still) isnt working, i received some weird vcf file.</description>
		<content:encoded><![CDATA[<p>The ebook &#8216;email system&#8217; (still) isnt working, i received some weird vcf file.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: coen</title>
		<link>http://www.timothysykes.com/comment-page-1/#comment-83253</link>
		<dc:creator>coen</dc:creator>
		<pubDate>Sun, 19 Apr 2009 15:20:50 +0000</pubDate>
		<guid isPermaLink="false">http://test.timothysykes.com/?p=5014#comment-83253</guid>
		<description>The ebook &#039;email system&#039; (still) isnt working, i received some weird vcf file.</description>
		<content:encoded><![CDATA[<p>The ebook &#8216;email system&#8217; (still) isnt working, i received some weird vcf file.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

